-
Perspective: Amid skyrocketing drug prices, it’s understandable that patients desperately need help affording medicine, especially when their health is on the line. But these programs create a mirage that perpetuates our health care system’s reckless spending.
-
A diabetes diagnosis is not always related to a person’s weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.
-
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
-
The number of pharmacies dispensing 340B discounted drugs soared to more than 31,000 this year. Drugmakers struck back by halting some discounts. Hospitals say they are losing millions of dollars — and cutting back services to patients — as a result.
-
Democrats agreed to a significant — but slimmed down — proposal to help lower prescription drug prices, bringing aboard notable holdouts on the measure, including Arizona Sen. Kyrsten Sinema.
-
More than 100 bills have been introduced in 42 states this year to regulate these companies, which serve as conduits for drug manufacturers, health insurers and pharmacies.
-
The agency is to decide by Monday whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November.
-
The move comes just days before a U.S. rule was set to go into effect allowing for bulk importation of drugs from Canada. Trump promised it would lower costs and be a "game changer" for seniors.
-
Three groups argue that HHS Secretary Alex Azar is “punting” to the states the responsibility for demonstrating the imports will be safe and save costs.
-
Two nearly identical drug implants have very different prices. The one for kids has a list price of $37,300. For adults, it's $4,400. A dad fought for his daughter to be able to get the cheaper drug.